Jane E Mayotte

US Patent:

20030232331, Dec 18, 2003

Filed:

Dec 4, 2001

Appl. No.:

10/005041

Inventors:

Stacie Casman - North Haven CT, US
Muralidhara Padigaru - Branford CT, US
Catherine Burgess - Wethersfield CT, US
Richard Shimkets - West Haven CT, US
Kimberly Spytek - New Haven CT, US
Jennifer Gilbert - Madison CT, US
Jane Mayotte - Middlefield CT, US
Jason Baumgartner - New Haven CT, US
Vishnu Mishra - Gainesville FL, US
Corine Vernet - Branford CT, US
Kevin Dickinson - Meriden CT, US
Robert Ballinger - Newington CT, US
Adam Wolenc - New Haven CT, US
Shlomit Edinger - New Haven CT, US
John MacDougall - Hamden CT, US
Glennda Smithson - Guilford CT, US
Karen Ellerman - Branford CT, US
David Stone - Guilford CT, US
Erik Gunther - Branford CT, US
Valerie Gerlach - Branford CT, US

International Classification:

C12Q001/68
G01N033/574
C07H021/04
C12P021/02
C12N005/06
C07K014/47
A61K048/00
C12N015/00

US Classification:

435/006000, 435/007230, 435/069100, 435/183000, 435/320100, 435/325000, 530/350000, 536/023200, 514/012000, 514/044000

Abstract:

Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.